H2AX and osteosarcoma: However, in lung adenocarcinoma, patients with low expression of H2AFX have a significantly better overall survival 40, and H2AFX can promote radioresistance in non-small cell lung cancer and osteosarcoma 13, 41, which reveal that H2AFX may also be a tumor promoter.